I accept We are using cookies to give you the best experience on our site. By continuing to use our website without changing the settings, you are agreeing to our use of cookies. You can find further information here.

The company

Founded in 1991, Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques – ranging from the traditional cell culture to the most innovating developments in the field of molecular biology. Vircell has been a successful market player worldwide, distributing its products in over 90 countries across the five continents.

The in-house production of all the antigens needed for the development of its kits enables Vircell to work with independence from external suppliers. This peculiarity makes it a flexible company able to guarantee the quality of its products. The reliability of its kits is the result of strict quality controls in accordance with international standards. Today, Vircell has all of its IVD products registered with the CE mark, according to current IVD regulations and has the quality certificates corresponding to ISO 9001 and ISO 13485. In addition, Vircell works following protocols that comply with GMP (FDA) regulations.

Mission

Vircell is a microbial biotechnology company which develops, manufactures and markets ready-to-use kits for the diagnosis of esoteric infectious diseases. Our business culture is based on our people, our high quality products, science, our know-how, and support through R&D.

Since the beginning Vircell has maintained three main objectives:

  1. Produce reagents of the highest quality.
  2. Maintain a clear customer orientation throughout the entire process, from product conception to after-sales service.
  3. Develop innovative products bringing significant advances.

Vision

We pursue the goal of becoming the gold standard for the microbiology sector by developing innovate products and techniques for the diagnosis of esoteric infectious diseases.

In order to become an even stronger international player, and to consolidate our global presence, our main goal is to take a step forward, both technically and quantitatively, within a 2-year time frame.

 

Newsletter

Receive all our news in your email